Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
T. Warkentin, A. Greinacher. (2004). Chest. Cited 812 times. https://doi.org/10.1378/CHEST.126.3_SUPPL.311SAntibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia.
C. Pouplard, M. May, S. Iochmann, et al.. (1999). Circulation. Cited 313 times. https://doi.org/10.1161/01.CIR.99.19.2530Anti-Platelet Factor 4/Heparin Antibodies: An Independent Predictor of 30-Day Myocardial Infarction After Acute Coronary Ischemic Syndromes
R. Williams, L. Damaraju, M. Mascelli, et al.. (2003). Circulation: Journal of the American Heart Association. Cited 103 times. https://doi.org/10.1161/01.CIR.0000066696.57519.AFHeparin-induced thrombocytopenia and cardiac surgery.
T. Warkentin, A. Greinacher. (2003). The Annals of thoracic surgery. Cited 57 times.Heparin-induced thrombocytopenia (HIT) in pediatric cardiac surgery: an emerging cause of morbidity and mortality.
B. Alsoufi, L. Boshkov, Aileen L. Kirby, et al.. (2004). Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual. Cited 54 times. https://doi.org/10.1053/J.PCSU.2004.02.024